Abstract
Introduction

AMP-activated protein kinase (AMPK) is a phylogenetically conserved serine/threonine protein kinase [1]; AMPK is a member of the SNF1/AMPK protein kinase family and is found in all eucaryotes
. It is a critical metabolic controller and stress sensor that is activated by nutrient deprivation, hypoxia/ischaemia, starvation, exercise and some therapeutic agents [1] . The name AMPK was first suggested in 1988 when Munday et al. showed that the enzyme formerly known as acetyl-CoA carboxylase (ACC) kinase-3 is the primary kinase responsible for regulation of the ACC Vmax [4] . Later, the name AMPK was used in 1989 by Carling et al. [5] , who demonstrated that AMPK is the major 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA) reductase kinase in rat liver. Activated AMPK not only stimulates a number of energy-producing metabolic pathways, but also inhibits energy-consuming pathways to reserve energy for cell survival. Thus, AMPK is a signal switch that monitors and regulates systemic and cellular energy status [6] . [7] . Increases in the AMP/ATP ratio activate AMPK by a number of mechanisms, including direct allosteric activation, and render it more easily phosphorylated by an AMP-dependent 
As the name suggests, AMPK activity increases in response to increases in the intracellular level of adenosine monophosphate (AMP), which generally occurs as a product of hydrolysis of adenosine triphosphate (ATP) in metabolic processes. In response to a reduction in energy charge (decrease in the ATP/AMP ratio), AMPK shuts down anabolic pathways such as fatty acid, triglyceride and cholesterol synthesis, as well as transcriptional processes that consume ATP, and switches on catabolic pathways that generate ATP, including fatty acid oxidation, glycolysis and protein decomposition
AMPK structure and function
AMPK is a heterotrimeric complex consisting of a catalytic ␣ subunit and regulatory ␤ and ␥ subunits [1] . The ␣ and ␤ subunits each exist as two isoforms: ␣1 and ␣2 and ␤1 and ␤2. The ␥ subunit has three known isoforms: ␥1, ␥2 and ␥3 [10, 11] . Although the C-terminal region of the ␣ subunit is required for association with the ␤/␥ subunits in both ␣1 and ␣2 isoforms, the subunits have distinct expression patterns. For example, in peripheral metabolic tissues, AMPK complexes containing the ␣1 catalytic subunit are mainly expressed in adipose tissue [12] [13] [14] , whereas those containing the ␣2 catalytic subunit pre-dominate in skeletal and heart muscle [15] [16] [17] . In central nervous system tissues, the ␣1 catalytic subunit is almost absent [18] . The serine/threonine kinase activity of AMPK is located at the ␣ subunit and is characterized by the presence of a threonine residue (Thr172) in a loop that must be phosphorylated for activation [19] [20] [21] 
Role of AMPK in the heart
The role of AMPK in the heart is currently under intensive study. The heart can be viewed simplistically as a circulating pump. In [63] . Fig. 1 ) [67] [68] . Chen et al. (1999) [75, 76] . In addition, metformin, a commonly used antidiabetes drug, reportedly exerts its therapeutic effects by activating the AMPK signalling pathway in endothelial cells [77] [78] [79] . The mechanisms underlying this protective effect include prevention of inflammatory cytokine production [77] and increased angiogenesis [79] . Rosiglitazone, an anti-diabetic drug in the thiazolidinedione class of drugs, not only protects endothelial cells against glucose-induced oxidative stress in an AMPK-dependent manner [80] but also stimulates nitric oxide synthesis in human aortic endothelial cells via AMPK [81] . In addition, some important hormones, such as adiponectin [82] [83] [84] , ghrelin [85] and leptin [86] [87] . Consistent with these reports, AMPK was also found to be a key regulator of the contractile response of pulmonary arteries to acute hypoxia [89, 90] . Therefore, AMPK is a player in the complex signalling pathways that regulate vascular smooth muscle tone. [92] . [93] . Interestingly, AMPK also contributes to the activation of NAD(P)H:quinone oxidoreductase 1, which can prevent arterial restenosis by suppressing VSMC proliferation [94] . [95] . Results [96] . These observations suggest that endothelial AMPK signalling may be a critical determinant of blood vessel recruitment to tissues exposed to ischaemic stress. Subsequently, the involvement of AMPK signalling in the proangiogenesis actions of adiponectin was observed [97] . Moreover, Yun et [100] . Although several other studies support this hypothesis [101, 102] , data from the studies of Zwetsloot et al. [103] suggest that AMPK is not necessary for the angiogenic response to exercise, indicating that the role of AMPK may be more complex than it currently appears.
Role of AMPK in endothelial cells
Apart from the acute regulation of vascular tone, AMPK is also involved in the proliferation of VSMC. AMPK expression blocks the growth of vascular smooth muscle induced by angiotensin-II [91]. In a rat femoral artery wire injury model, continuous activation of AMPK by AICAR injection significantly inhibits neointima formation [91]. Igata et al. showed that AMPK increased the expression of the cyclin-dependent kinase inhibitor p21cip via inhibition of phosphorylation of the retinoblastoma gene product, leading to inhibition of the proliferation of vascular smooth muscle
Moreover, Liang et al. demonstrated that berberine, a herbal extract, inhibits platelet-derived growth factor-induced growth and migration in VSMCs, partly through the AMPK pathway
Role of AMPK in vascular angiogenesis
Angiogenesis is a physiological process involving the growth of new blood vessels from pre-existing vessels. It represents a normal and pivotal biological process in growth and development and is also important in wound healing and tumour growth. A critical role for AMPK in angiogenesis was first identified in cancer cells under nutrient deprivation. The introduction of AMPK antisense RNA expression vectors into pancreatic cancer cell lines, PANC-1 and AsPC-1, diminished their tolerance to glucose deprivation; in addition, the stable transfection of AMPK antisense RNA into PANC-1 cells inhibited tumour growth in nude mice
from the studies of Nagata et al. demonstrated that AMPK signalling was a potent regulator of vascular angiogenesis and was specifically required for endothelial cell migration and differentiation under conditions of hypoxia
Role of AMPK in cardiovascular diseases
Atherosclerosis
Atherosclerosis is a chronic disease affecting medium and large arteries. In the past several decades, there has been a marked increase in our understanding of the pathogenesis of this vascular disorder [104] . [107] . Moreover, AMPK activation was found to contribute to the activity of adiponectin, which inhibits insulin-like growth factor-1 induced cell migration in VSMCs [108] . AMPK regulates the antioxidant status of vascular endothelial cells [109] , and reduction of AMPK increases endoplasmic reticulum stress and atherosclerosis in vivo [110] . In the latter report, Dong et al. also demonstrated that AMPK ␣2 is the main physiological suppressor of endoplasmic reticulum stress in endothelial cells [110] . Notably, AMPK suppresses oxidized low-density lipoprotein-induced macrophage proliferation, which is a key event underlying the development of atherosclerosis [111] [77] , which is pivotal in development of hypertension [113] . Moreover, impaired adiponectin-AMPK signalling has been reported in insulin-sensitive tissues of hypertensive rats by RodrÌguez et al. [114] . Recently, it was further reported that deletion of AMPK ␣2 enhances the increase of phosphate-4E binding protein-1 seen in transverse aortic constriction and augments the T transverse aortic constriction-induced increase of phosphateAkt, indicating that the AMPK signalling pathway exerts a cardiac protective effect against pressure-overload-induced ventricular hypertrophy and dysfunction [115] . Collectively, the results from these studies support the notion that AMPK is protective against hypertension. However, it should be noted that activation of AMPK was found to enhance angiotensin II-induced proliferation in cardiac fibroblasts [116] 
Previously, atherosclerosis was presumed to be primarily a plumbing problem. Now it is deemed a chronic inflammatory disease in the walls of arteries, which originates from the interaction between cells of the arterial wall, lipoproteins and inflammatory cells, leading to the development of complex lesions or plaques. AMPK not only regulates proliferation, migration, apoptosis and autophagy of vascular endothelial and smooth muscle cells but also affects biological functions of macrophages, which are critical activators of atherosclerosis. Also relevant to the development of atherosclerosis is the fact that AMPK participates in whole body glucose, lipid and protein homeostasis, thus affecting serum lipid and glucose levels and insulin resistance. Therefore, it is an attractive hypothesis that AMPK-mediated signalling is intimately involved in the pathophysiological process of atherosclerosis. The entry of vascular cells, especially VSMCs, into the cell cycle plays an important role in the development and progression of atherosclerosis. Studies have reported that treatment of human aortic smooth muscle cells (HASMC), with the AMPK activator AICAR results in phosphorylation of AMPK and ACC while significantly inhibiting HASMC proliferation induced by either plateletderived growth factor-BB or fetal calf serum [92]. Cell cycle analysis showed that AMPK activation increases the number of cells in G0/G1-phase and reduces numbers in S-and G2/M-phase
Ischaemic stroke
Whether AMPK is beneficial or detrimental to the ischaemic brain is in dispute. Evidence from several independent groups indicates that AMPK is neuroprotective in ischaemic stroke [117] [118] [119] , whereas there are also reports showing activation of AMPK is harmful in ischaemic stroke [120] [121] [119] . Dasgupta et al. found that resveratrol protects neurons through stimulation of AMPK activity [118] . Also, AMPK is associated with GABA(B) receptors, serving to enhance neuronal survival after ischaemia [32, 117] . It is worth noting that the detrimental effects of AMPK in stroke have been reported by only one group [120, 121] . Future studies using more selective AMPK activators or inhibitors, selective genetic manipulation in animal models and isolated genetic knockout neuronal cells will provide more information on this role of AMPK in stroke.
Conclusion and perspectives
Although the AMPK pathway is traditionally thought of as an intracellular fuel switch and controller of metabolism, the significance of AMPK in the cardiovascular system has recently been recognized [123] . 
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